Tissue- and Liquid-Based Biomarkers in Prostate Cancer Precision Medicine

Tissue- and Liquid-Based Biomarkers in Prostate Cancer Precision Medicine

Worldwide, prostate cancer (PC) is the second-most-frequently diagnosed male cancer and the fifth-most-common cause of all cancer-related deaths. Suspicion of PC in a patient is largely based upon clinical signs and the use of prostate-specific antigen (PSA) levels. Although PSA levels have been cri...

Full description

Bibliographic Details
Main Authors: James Meehan, Mark Gray, Carlos Martínez-Pérez, Charlene Kay, Duncan McLaren, Arran K. Turnbull
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Journal of Personalized Medicine
Subjects:
prostate cancer
precision medicine
tissue-based biomarkers
liquid-based biomarkers
Online Access:https://www.mdpi.com/2075-4426/11/7/664

Similar Items

Similar Items